Metastatic Melanoma Cancer Diagnostic Market

Metastatic Melanoma Cancer Diagnostic Market Study by Biopsy, Chest X-ray, Ultrasound, CT SCAN, MRI, and PET SCAN from 2024 to 2034

Analysis of Metastatic Melanoma Cancer Diagnostic Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Metastatic Melanoma Cancer Diagnostic Market Outlook (2024 to 2034)

The metastatic melanoma cancer diagnostic market is estimated to be valued at US$ 3,632.6 million in 2024. Projections indicate a healthy expansion with a CAGR of 7.70% through 2034. Anticipated growth is set to propel the market to an impressive size of US$ 7,601.0 million by 2034.

Advancements in early detection technologies contribute to increased diagnosis rates, fueling the market growth. In the last few years, there has been a rise in the incidences of metastatic melanoma cancer in the general population. This has significantly pushed the demand for effective treatments and procedures that mitigate the impact of metastatic melanoma.

The metastatic melanoma cancer diagnostic market generated an estimated revenue of US$ 2,670.3 million in 2019. In five years, the market grew at a pace of 6.34% and added a revenue of US$ 962.3 million.

Report Attributes Details
Estimated Market Value (2024E) US$ 3,632.6 million
Forecasted Market Value (2034F) US$ 7,601.0 million
Global Market Growth Rate (2024 to 2034) 7.70% CAGR
Biopsy Segment Growth Rate (2024 to 2034) 27.0%
Pathology Laboratories Segment Growth Rate (2024 to 2034) 51.8%
North America Market Share (2024) 47.60%
East Asia Market Share (2024) 2.20%
Key Companies Profiled
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Qiagen
  • Bristol Myers Squibb
  • Illumina
  • Bio-Rad Laboratories
  • Myriad Genetics
  • Genomic Health
  • Agilent Technologies
  • Exact Sciences Corporation
  • BioMérieux
  • Hologic, Inc.
  • NanoString Technologies
  • Guardant Health
  • Sysmex Corporation
  • Foundation Medicine
  • GRAIL
  • Menarini Silicon Biosystems

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Factors Have Driven the Global Surge in Metastatic Melanoma Cancer Diagnostic Demand?

“Increasing Incidence Rates and Public Awareness and Education to Complement the Demand for Metastatic Melanoma Cancer Diagnostic Treatments”

According to a survey conducted by the National Library of Medicine, melanoma is a common cutaneous malignancy after basal cell carcinoma and squamous cell carcinoma. These rising incidences have driven the global demand for metastatic melanoma cancer diagnostics in the medicare industry.

Post-pandemic, the general population worldwide is also pushing toward preventive care rather than solely focusing on reactive healthcare measures. Individuals are concerned about the dangers of skin cancer and the importance of early detection. This has pushed them to seek regular screenings and consultations, subsequently driving up diagnostic demand.

“Advancements in Diagnostic Technologies, and Government Initiatives to Amplify Market Growth”

In the last few decades, the Medicare sector has undergone a noticeable transition. These ongoing developments in diagnostic technologies, such as molecular profiling, imaging techniques, and biomarker identification, have significantly enhanced the capabilities of the medicare sector, particularly in the domain of cancer diagnostics. It is because of these innovations that patients are increasingly trusting metastatic melanoma cancer diagnostics, thus expanding the market growth.

Governments in countries like India, the United States, China, Japan, etc., are also investing heavily to promote awareness regarding the prevention and early detection of cancer. Government-led diagnostic centers and testing camps also bring a substantial amount of potential consumers to the market.

Which Factors Present Challenges to the Expansion of the Metastatic Melanoma Cancer Diagnostic Market?

“Limited Awareness and Education, Cost of Advanced Diagnostics, and Global Economic Factors to Slow down Market Growth”

Limited awareness and education among the general population about the benefits of metastatic melanoma cancer diagnostic treatments is slowing down the market growth. Despite the active promotion by the government as well as private healthcare facilities, there remains a considerable knowledge gap in the common population regarding this, which is significantly hampering the market growth. This factor keeps a substantial amount of cost-sensitive consumers, especially from underdeveloped and developing parts of the world, away from the market. Besides this, global economic factors, such as recessionary economies and financial uncertainties, also slow down the market growth for metastatic melanoma cancer diagnostic treatments.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

The North American metastatic melanoma cancer diagnostic market is poised for exceptional growth, projecting a healthy CAGR of 8.40% through 2034. The surge is primarily attributed to increasing demand for metastatic melanoma cancer diagnostics in key countries, notably the United States and Mexico. In 2024, the United States dominates the metastatic melanoma cancer diagnostic industry with an estimated 83.10% market share. Meanwhile, the market for metastatic melanoma cancer diagnostic in East Asia is anticipated to exhibit substantial progress, aiming for a 10.20% CAGR in 2024. In this region, China emerges as the key player in the industry, commanding a significant share of 76.20% in 2024.

Why is the United States Leading the Metastatic Melanoma Cancer Diagnostic Market in the North American Region?

“Advanced Healthcare Infrastructure and High Incidence Rates in the Country to Augment Growth”

The North American market stood at US$ 1,728 million in 2024, acquiring a revenue share of 47.6%, and is further projected to expand at a CAGR of 8.40% through 2034. The United States metastatic melanoma cancer diagnostic industry is estimated to be worth US$ 1,436 million in 2024. The demand for metastatic melanoma cancer diagnostic in the United States is projected to rise at a CAGR of 8.7% through 2034.

The United States of America is blessed with several drivers, making it the leading country in the metastatic melanoma cancer diagnostic market. The country has one of the advanced and sophisticated healthcare ecosystem, with progressive medical facilities, laboratories, and diagnostic centers. This infrastructure enables rapid adoption and implementation of advanced diagnostic tools for metastatic melanoma. Besides this, the United States is one of the leading countries in metastatic melanoma cancer incidences. All these factors have positioned the United States as one of the top countries in this market.

Why is China Commanding the East Asian Metastatic Melanoma Cancer Diagnostic Market?

“Healthcare Facilities and Expertise, and Rising Medical Tourism to Help Market Expansion”

The China metastatic melanoma cancer diagnostic industry is estimated to be worth US$ 60 million in 2024, garnering a share of 76.2% in the East Asian region. The sales of metastatic melanoma cancer diagnostic are likely to record a CAGR of 10.4% through 2034.

China's investment in developing world-class healthcare facilities, coupled with advancements in medical research and technology, has enhanced its capabilities in cancer diagnostics. This has made the adoption of advanced diagnostic technologies more prevalent in the country. Besides this, the presence of skilled healthcare professionals has appreciably contributed to the country's leadership in the metastatic melanoma cancer diagnostic market. The country is also an international hub for medical tourism. Every year, millions of patients from across the world flock to the country for its world-class healthcare facilities.

Category-wise Insights

Based on the test type, the biopsy segment is estimated to hold a 27.0% market share in 2024. Simultaneously, the PET scan segment is anticipated to secure a 32.0% share, contributing significantly to the market's resource diversity and stability. Based on end users, the pathology laboratories segment marks its dominance in the metastatic melanoma cancer diagnostic industry, with a share of 51.80% in 2024.

Why are Pathology Laboratories Relying on Metastatic Melanoma Cancer Diagnostic Solutions Skin Cancers?

“Precision and Accuracy and Early Detection and Staging Makes Metastatic Melanoma Cancer Diagnostic a Perfect Choice”

Metastatic melanoma cancer diagnostic treatments are gaining a lot of impetus in the healthcare industry, primarily due to their precision and accuracy in identifying the nature and characteristics of melanoma cells. Pathologists rely on these solutions to ensure accurate diagnosis and staging, guiding appropriate treatment strategies.

The demand for metastatic melanoma cancer diagnostic treatments in pathology laboratories is also skyrocketing due to its ability to help detect the cancer in its early stages. This reduces the complexities and improves the success rates for treatment interventions. Pathology laboratories also prefer these methodologies as they offer a more comprehensive assessment of metastatic melanoma. These benefits collectively contribute to advancements in patient care, further contributing to the widespread market adoption.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Competitive Landscape

The global market for metastatic melanoma cancer diagnosis consists of a multitude of companies, such as Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Abbott Laboratories, Qiagen, etc. These industry giants have a strong foothold in the global market for metastatic melanoma cancer diagnostic treatments due to their prolonged presence and experience. They also invest in the research and development of advanced diagnostic technologies. Small companies have to rely on these companies to implement technological additions to their equipment.

Recent Development

  • In February 2023, Avero Diagnostics successfully launched AMBLor, a groundbreaking laboratory test for early-stage melanoma identification at low risk of progression. The technology was licensed from AMLo Biosciences in September 2022.
  • In June 2023, DeepX Diagnostics received FDA 510(k) clearance for its digital dermatoscope, DermoSight. Having conducted over 180,000 assessments in Europe, it is set to enter the U.S. market.
  • In February 2023, Dermalyser exhibited promise, demonstrating a 95% sensitivity and 86% specificity in primary care settings, offering a potential AI-driven solution to identify malignant melanomas and alleviate dermatologists' workloads.

Metastatic Melanoma Cancer Diagnostic Market - Segmentation

  • By Test:

    • Biopsy
      • Local excision/excisional biopsy
      • Punch biopsy
      • Shave biopsy
      • Fine needle aspiration (FNA) biopsy
      • Sentinel lymph node biopsy
    • Chest X-ray
    • Ultrasound
    • CT Scan
    • MRI
    • PET SCAN
  • By Service Provider:

    • Hospitals
    • Pathology Laboratories
    • Cancer Research Centres
  • By Region:

    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • The Middle East & Africa (MEA)

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Test, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test, 2024 to 2034

        5.3.1. Biopsy

            5.3.1.1. Local excision/excisional biopsy

            5.3.1.2. Punch biopsy

            5.3.1.3. Shave biopsy

            5.3.1.4. Fine needle aspiration (FNA) biopsy

            5.3.1.5. Sentinel lymph node biopsy

        5.3.2. Chest X-ray

        5.3.3. Ultrasound

        5.3.4. CT Scan

        5.3.5. MRI

        5.3.6. PET SCAN

    5.4. Y-o-Y Growth Trend Analysis By Test, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Test, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Provider

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Service Provider, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Provider, 2024 to 2034

        6.3.1. Hospitals

        6.3.2. Pathology Laboratories

        6.3.3. Cancer Research Centres

    6.4. Y-o-Y Growth Trend Analysis By Service Provider, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Service Provider, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Test

        8.2.3. By Service Provider

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Test

        8.3.3. By Service Provider

    8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Test

        9.2.3. By Service Provider

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test

        9.3.3. By Service Provider

    9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Test

        10.2.3. By Service Provider

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test

        10.3.3. By Service Provider

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Test

        11.2.3. By Service Provider

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test

        11.3.3. By Service Provider

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Test

        12.2.3. By Service Provider

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test

        12.3.3. By Service Provider

    12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Test

        13.2.3. By Service Provider

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test

        13.3.3. By Service Provider

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Test

        14.2.3. By Service Provider

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test

        14.3.3. By Service Provider

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2023

            15.1.2.1. By Test

            15.1.2.2. By Service Provider

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2023

            15.2.2.1. By Test

            15.2.2.2. By Service Provider

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2023

            15.3.2.1. By Test

            15.3.2.2. By Service Provider

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2023

            15.4.2.1. By Test

            15.4.2.2. By Service Provider

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2023

            15.5.2.1. By Test

            15.5.2.2. By Service Provider

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2023

            15.6.2.1. By Test

            15.6.2.2. By Service Provider

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2023

            15.7.2.1. By Test

            15.7.2.2. By Service Provider

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2023

            15.8.2.1. By Test

            15.8.2.2. By Service Provider

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2023

            15.9.2.1. By Test

            15.9.2.2. By Service Provider

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2023

            15.10.2.1. By Test

            15.10.2.2. By Service Provider

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2023

            15.11.2.1. By Test

            15.11.2.2. By Service Provider

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2023

            15.12.2.1. By Test

            15.12.2.2. By Service Provider

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2023

            15.13.2.1. By Test

            15.13.2.2. By Service Provider

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2023

            15.14.2.1. By Test

            15.14.2.2. By Service Provider

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2023

            15.15.2.1. By Test

            15.15.2.2. By Service Provider

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2023

            15.16.2.1. By Test

            15.16.2.2. By Service Provider

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2023

            15.17.2.1. By Test

            15.17.2.2. By Service Provider

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2023

            15.18.2.1. By Test

            15.18.2.2. By Service Provider

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2023

            15.19.2.1. By Test

            15.19.2.2. By Service Provider

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2023

            15.20.2.1. By Test

            15.20.2.2. By Service Provider

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2023

            15.21.2.1. By Test

            15.21.2.2. By Service Provider

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2023

            15.22.2.1. By Test

            15.22.2.2. By Service Provider

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2023

            15.23.2.1. By Test

            15.23.2.2. By Service Provider

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Test

        16.3.3. By Service Provider

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Thermo Fisher Scientific Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Quest Diagnostics Incorporated

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. BioMerieux SA

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. QIAGEN

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Illumina Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Inivata Ltd.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. F. Hoffman-La Roche Ltd.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Agilent Technologies Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Abbott

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Myriad genetics

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 5: North America Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 6: North America Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: Latin America Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 9: Latin America Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 11: Western Europe Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 12: Western Europe Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 15: Eastern Europe Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: East Asia Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 21: East Asia Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Test, 2019 to 2034

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Service Provider, 2019 to 2034

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Market Value (US$ Million) by Test, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 7: Global Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 13: Global Market Attractiveness by Test, 2024 to 2034

Figure 14: Global Market Attractiveness by Service Provider, 2024 to 2034

Figure 15: Global Market Attractiveness by Region, 2024 to 2034

Figure 16: North America Market Value (US$ Million) by Test, 2024 to 2034

Figure 17: North America Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 23: North America Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 24: North America Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 28: North America Market Attractiveness by Test, 2024 to 2034

Figure 29: North America Market Attractiveness by Service Provider, 2024 to 2034

Figure 30: North America Market Attractiveness by Country, 2024 to 2034

Figure 31: Latin America Market Value (US$ Million) by Test, 2024 to 2034

Figure 32: Latin America Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 43: Latin America Market Attractiveness by Test, 2024 to 2034

Figure 44: Latin America Market Attractiveness by Service Provider, 2024 to 2034

Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 46: Western Europe Market Value (US$ Million) by Test, 2024 to 2034

Figure 47: Western Europe Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 52: Western Europe Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 58: Western Europe Market Attractiveness by Test, 2024 to 2034

Figure 59: Western Europe Market Attractiveness by Service Provider, 2024 to 2034

Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 61: Eastern Europe Market Value (US$ Million) by Test, 2024 to 2034

Figure 62: Eastern Europe Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 73: Eastern Europe Market Attractiveness by Test, 2024 to 2034

Figure 74: Eastern Europe Market Attractiveness by Service Provider, 2024 to 2034

Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 76: South Asia and Pacific Market Value (US$ Million) by Test, 2024 to 2034

Figure 77: South Asia and Pacific Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 88: South Asia and Pacific Market Attractiveness by Test, 2024 to 2034

Figure 89: South Asia and Pacific Market Attractiveness by Service Provider, 2024 to 2034

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 91: East Asia Market Value (US$ Million) by Test, 2024 to 2034

Figure 92: East Asia Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 97: East Asia Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 100: East Asia Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 101: East Asia Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 103: East Asia Market Attractiveness by Test, 2024 to 2034

Figure 104: East Asia Market Attractiveness by Service Provider, 2024 to 2034

Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 106: Middle East and Africa Market Value (US$ Million) by Test, 2024 to 2034

Figure 107: Middle East and Africa Market Value (US$ Million) by Service Provider, 2024 to 2034

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Test, 2019 to 2034

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Test, 2024 to 2034

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test, 2024 to 2034

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Service Provider, 2019 to 2034

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Service Provider, 2024 to 2034

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Service Provider, 2024 to 2034

Figure 118: Middle East and Africa Market Attractiveness by Test, 2024 to 2034

Figure 119: Middle East and Africa Market Attractiveness by Service Provider, 2024 to 2034

Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What was the Value of the Metastatic Melanoma Cancer Diagnostic Market in 2019?

The global metastatic melanoma cancer diagnostic market was worth US$ 2,670.3 million in 2019.

What is the Sales Outlook for Metastatic Melanoma Cancer Diagnostic in 2024?

The sales outlook for metastatic melanoma cancer diagnostic is likely to be valued at US$ 3,632.6 million in 2024.

What is the Demand Forecast for Metastatic Melanoma Cancer Diagnostics for the decade?

Demand for metastatic melanoma cancer diagnostic is expected to reach a market value of US$ 7,601.0 million by the end of 2034.

What is the Adoption Growth Projection for Metastatic Melanoma Cancer Diagnostic Solutions?

The adoption of metastatic melanoma cancer diagnosis is projected to rise at a CAGR of 7.70% through 2034.

At What Rate Is the Market in North America Predicted to Grow?

The North American market for metastatic melanoma cancer diagnosis is forecast to expand at a CAGR of 8.40% through 2034.

- Also of Interest -

Melanoma Cancer Diagnostics Market

Melanoma Cancer Diagnostics Market Analysis by Fluorescent In-Situ Hybridization (FISH) Tests, Comparative Genomic Hybridization (CGH) Tests, and Immunohistochemical (IHC) Tests from 2023 to 2033

Ovarian Cancer Diagnostics Market

Ovarian Cancer Diagnostics Market By Cancer Type (Epithelial Tumor Diagnostics, Germ Cell Carcinoma Tumor Diagnostics, Stromal Carcinoma Tumor Diagnostics), By Test Type, By End User - Forecast to 2021–2031

Blood Cancer Diagnostics Market

Blood Cancer Diagnostics Market By Test (CBC Tests for Blood Cancer Diagnostics, CTC Tests, Blood Protein Testing, Liquid Biopsy, Bone Marrow Biopsy), By End User, By Region - Global Market Insights 2022–2032

Lung Cancer Diagnostics Market

Lung Cancer Diagnostics Market Study by CA Tests, HER2 Tests, ALK Tests, Angiogenesis Inhibitors, EGFR Mutation Tests, and KRAS Mutation Tests from 2024 to 2034

Metastatic Melanoma Cancer Diagnostic Market

Schedule a Call